Participate in Quizzes daily and WIN POINTS!

Quiz on Congenital Cytomegalovirus Causes, Symptoms, and Treatment

Dear doctors participate in this fun and exciting quiz on Congenital cytomegalovirus. Congenital cytomegalovirus (CMV) infection occurs when the virus is passed from mother to baby during pregnancy, potentially leading to hearing loss, vision problems, and developmental delays in infants. Discovered in the 1950s, CMV is now managed with antivirals like ganciclovir for symptomatic cases, while preventive measures are emphasized. Participate Now.

1. Which of the following is the most common clinical manifestation of congenital CMV infection in infants?

2. What is the primary method for diagnosing congenital CMV infection in an infant?

3. In which scenario is antiviral therapy for congenital CMV most strongly recommended?

4. Which of the following antiviral agents is most commonly used to treat symptomatic congenital CMV infection?

5. Which of the following strategies is recommended for preventing congenital CMV infection in pregnant women?

Recommended Quizzes

Quiz On Acute Respiratory Distress Syndrome (Ards)


Quiz On Infant Chronic Diseases


Quiz On Impetigo Management


Quiz on Congenital Disorder Management


Quiz On Pediatric Immunization


Quiz On Down Syndrome


Quiz on Pediatric child hygiene


Quiz on Pediatric Rare Diseases


Quiz On Paediatric Feeding Disorder


Quiz On Pediatric Dental Care


Quiz on Pediatric Emergency Medicine: Essential Skills for Managing Acute Pediatric Conditions


Quiz On Child Obesity


Quiz on Pediatric Neurocritical Care


Quiz On Hepatitis Management


Quiz On Pediatric Vaccine


Quiz on Craniosynostosis Management


Quiz on Preventing Childhood Obesity


Quiz On Meningitis Management


Quiz on Ocular Blood Flow in Preterm Neonates


Quiz On Growth Hormone Deficiency



Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ALK-positive lung cancer trial results show unprecedented progression-free survival.

2.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

3.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

4.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

5.

Resection for Early Liver Cancer Tied to Improved Survival.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes


Whats more on Hidoc Dr.


Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Participate and win exciting prizes

Participate and win cash vouchers

Get updates on the latest events happening around the world


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot